XML 25 R15.htm IDEA: XBRL DOCUMENT v3.19.1
Stock-Based Compensation
3 Months Ended
Mar. 31, 2019
Text Block [Abstract]  
Stock-Based Compensation
9. Stock-Based Compensation
 
The Company recognized stock-based compensation expense on all employee and non-employee awards as follows:
 
 
 
For the three months ended March 31,
 
(in thousands)
 
2019
 
 
2018
 
Research and development
 
$
433
 
 
$
603
 
General and administrative
 
 
1,023
 
 
 
3,056
 
Stock-based compensation expense
 
$
1,456
 
 
$
3,659
 
 
The Company granted an aggregate of 1,496,333 stock options during the three months ended March 31, 2019 with a weighted-average grant date fair value of $1.62 per share. The Company granted an aggregate of 7,500 stock options during the three months ended March 31, 2018 with a weighted-average grant date fair value of $3.00 per share.
 
The Company recognizes
forfeitures
as they occur.
 
For the three months ended March 31, 2019 and 2018, the fair value of stock options was estimated on the date of grant using a Black-Scholes option valuation model with the following assumptions:
 
 
  
For the three months ended March 31,
 
  
2019
 
2018
Risk-free interest rate
  
2.28 - 2.53%
 
2.56 - 2.74%
Expected life in years
  
6 - 6.25
 
6
Expected volatility
  
78.87 - 85.00%
 
80.75 - 81.10%
Expected dividend yield
  
0
 
0
 
 
Stock option activity under the Company’s stock option plan for the three months ended March 31, 2019 is as follows:
 
(in thousands, except share and per share data)
 
Number of

Shares
 
 
Weighted-

Average Exercise

Price
 
 
Weighted-

Average

Contractual

Term 
(Years)
 
 
Aggregate

Intrinsic Value
 
Outstanding, December 31, 2018
 
 
5,277,085
 
 
$
4.24
 
 
 
 
 
 
 
 
 
Granted
 
 
1,496,333
 
 
 
2.24
 
 
 
 
 
 
 
 
 
Exercised
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cancelled
 
 
(1,357,333
)
 
 
4.33
 
 
 
 
 
 
 
 
 
Outstanding, March 31, 2019
 
 
5,416,085
 
 
$
3.66
 
 
 
7.82
 
 
$
5,494
 
Options exercisable, March 31, 2019
 
 
2,213,008
 
 
$
5.14
 
 
 
5.33
 
 
$
1,025
 
Options exercisable, December 31, 2018
 
 
3,099,935
 
 
$
5.15
 
 
 
4.93
 
 
$
88
 
Options available for future grant
 
 
3,996,638
 
 
 
 
 
 
 
 
 
 
 
 
 
 
At March 31, 2019, total unrecognized compensation costs related to unvested stock options outstanding amounted to $6.2 million. The cost is expected to be recognized over a weighted-average period of 1.61 years.
 
A summary of the status of unvested restricted stock for the three months ended March 31, 2019 is as follows:
 
 
 
Number of Shares
 
 
Weighted-Average

Grant Date Fair Value
 
Non-vested, December 31, 2018
 
 
682,070
 
 
$
3.47
 
Granted
 
 
1,393,536
 
 
 
2.24
 
Vested
 
 
(446,428
)
 
 
2.24
 
Cancelled
 
 
(7,333
)
 
 
4.14
 
Non-vested, March 31, 2019
 
 
1,621,845
 
 
$
2.92
 
 
At March 31, 2019, total unrecognized compensation costs related to unvested restricted stock outstanding amounted to $4.1 million. The cost is expected to be recognized over a weighted-average period of 1.59 years.